Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
1998 1
2005 1
2006 1
2008 1
2010 1
2011 1
2014 2
2015 1
2016 1
2018 2
2020 1
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP).
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators. Butzkueven H, et al. J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):660-668. doi: 10.1136/jnnp-2019-322326. Epub 2020 Mar 31. J Neurol Neurosurg Psychiatry. 2020. PMID: 32234967 Free PMC article.
[Drug-induced eosinophilic pneumonia].
Schelhorn J, Höfer L, Syrbe G, Polzer U. Schelhorn J, et al. Among authors: polzer u. Nervenarzt. 2008 Jun;79(6):696-8. doi: 10.1007/s00115-008-2437-y. Nervenarzt. 2008. PMID: 18324382 German.
Facial affect recognition in the course of schizophrenia.
Wölwer W, Streit M, Polzer U, Gaebel W. Wölwer W, et al. Among authors: polzer u. Eur Arch Psychiatry Clin Neurosci. 1996;246(3):165-70. doi: 10.1007/BF02189118. Eur Arch Psychiatry Clin Neurosci. 1996. PMID: 8739402 Clinical Trial.
Efficacy and safety of high-dose cabergoline in Parkinson's disease.
Odin P, Oehlwein C, Storch A, Polzer U, Werner G, Renner R, Shing M, Ludolph A, Schüler P. Odin P, et al. Among authors: polzer u. Acta Neurol Scand. 2006 Jan;113(1):18-24. doi: 10.1111/j.1600-0404.2005.00514.x. Acta Neurol Scand. 2006. PMID: 16367894 Clinical Trial.
Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropinirole.
Eggert K, Öhlwein C, Kassubek J, Wolz M, Kupsch A, Ceballos-Baumann A, Ehret R, Polzer U, Klostermann F, Schwarz J, Fuchs G, Jost W, Albert A, Haag A, Hermsen A, Lohmüller K, Kuhn K, Wangemann M, Oertel WH; In Cooperation With the German Competence Network on Parkinson’s Disease. Eggert K, et al. Among authors: polzer u. Clin Neuropharmacol. 2014 Jul-Aug;37(4):116-22. doi: 10.1097/WNF.0000000000000041. Clin Neuropharmacol. 2014. PMID: 24992083 Clinical Trial.
16 results